BioNTech
BNTX
$86.88
Share price
0.82%
Change (1 day)
-29.47%
Change (1 year)
Operating Margin for BioNTech (BNTX)
Operating Margin as of April 2024 (TTM): 66.14%
According to BioNTech's latest financial reports and stock price the company's current Operating Margin is 66.14%. At the end of 2022 the company had an Operating Margin of 74.83%.
Operating Margin history for BioNTech from 2019 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 74.83% | -5.62% |
| 2021 | 79.29% | -362.29% |
| 2020 | -30.23% | -81.71% |
| 2019 | -165.25% | 342.31% |
| 2018 | -37.36% | -73.21% |
| 2017 | -139.46% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.